United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$40Mraised across 3 rounds since 2013, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $11M sold, first sale Aug 2017
From a historical funding record
Reported by pevc.dowjones.com
From the SEC filings it signed: 1 on the team.
On the board, as filediBruce BoothKees BeenSamantha Singer
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Atlas Venture
Google Ventures
Hatteras Venture Partners
Third Point VenturesRemeditexAtlas Venture/ GVMissing a round, or an investor who was in one? Tell us.
Rodin Therapeutics's investors include Atlas Venture, Johnson & Johnson Development Corporation (JJDC), Google Ventures, Hatteras Venture Partners and Third Point Ventures, and 2 more on record.
Rodin Therapeutics has raised $40M across 3 rounds since 2013. One round did not disclose an amount, so the total is a floor.
Rodin Therapeutics's most recent round was a Series C of $27M in Sept 2017.
Its most recent round, $27M in Sept 2017, is also its largest on record.
Rodin Therapeutics's first round on record, in Jun 2013, was backed by Atlas Venture and Johnson & Johnson Development Corporation (JJDC).
Rodin Therapeutics's latest named round is a Series C, in Sept 2017.
Rodin Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
